BIOSYNTH Trademark

Trademark Overview


On Monday, June 13, 2016, a trademark application was filed for BIOSYNTH with the United States Patent and Trademark Office. The USPTO has given the BIOSYNTH trademark a serial number of 87069542. The federal status of this trademark filing is SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED as of Tuesday, December 12, 2023. This trademark is owned by Biosynth AG. The BIOSYNTH trademark is filed in the Pharmaceutical Products category with the following description:

Medicinal preparations for photosensitizing agents used as a dermatologic drug or prodrug for the treatment of skin cancer by phototherapy; Chemical reagents for medical and veterinarian use; Chemical reagents for cultures of microorganisms for medical use, namely, in culture media for the isolation and identification of the bacteria strain Escherichia coli O157:H7; Chemical preparations for medical purposes, namely, for Cholesterol testing to prevent possible consequences of Hypercholesterolemia such as atherosclerosis, coronary heart disease and other forms of cardiovascular diseases; Chemical preparations for medical purposes, namely, for novel enzyme responsive inhibitors that allow for modifications of the composition of microbial communities; Chemical preparations for medical purposes, namely, for immunology research; Organic chemical preparations for medical purposes, namely, immunomodulatory compounds with anti-inflammatory properties; Organic chemical preparations for medical ...
biosynth

General Information


Serial Number87069542
Word MarkBIOSYNTH
Filing DateMonday, June 13, 2016
Status702 - SECTION 8 & 15 - ACCEPTED AND ACKNOWLEDGED
Status DateTuesday, December 12, 2023
Registration Number5287408
Registration DateTuesday, September 12, 2017
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, November 22, 2016

Trademark Statements


Goods and ServicesMedicinal preparations for photosensitizing agents used as a dermatologic drug or prodrug for the treatment of skin cancer by phototherapy; Chemical reagents for medical and veterinarian use; Chemical reagents for cultures of microorganisms for medical use, namely, in culture media for the isolation and identification of the bacteria strain Escherichia coli O157:H7; Chemical preparations for medical purposes, namely, for Cholesterol testing to prevent possible consequences of Hypercholesterolemia such as atherosclerosis, coronary heart disease and other forms of cardiovascular diseases; Chemical preparations for medical purposes, namely, for novel enzyme responsive inhibitors that allow for modifications of the composition of microbial communities; Chemical preparations for medical purposes, namely, for immunology research; Organic chemical preparations for medical purposes, namely, immunomodulatory compounds with anti-inflammatory properties; Organic chemical preparations for medical laboratory analysis purposes, namely, for medical detection, identification and quantification of strains of pathogenic bacteria; Chemical preparations for medical laboratory analysis purposes, namely, for medical immunological and microbiological blood testing; Chemical preparations for medical laboratory analysis purposes, namely, used as a routine medical supplement to blood culture media in vitro to inhibit blood coagulation and to improve the detection limits for individual microorganisms; Chemical preparations for medical laboratory analysis purposes, namely, for medical detection of pathogenic bacteria, namely, various strains of Listeria, Clostridium, Bacillus and Staphylococcus; Chemical preparations for medical laboratory analysis purposes, namely, for the medical detection and quantification of bacteria strains of Escherichia coli; Medical preparations for the diagnosis of Staphylococus aureus, in particular for Methicillin-resistant Staphylococcus aureus (MRSA); Medical enzyme

Classification Information


International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateMonday, June 20, 2016
Primary Code005
First Use Anywhere DateFriday, September 29, 2006
First Use In Commerce DateFriday, September 29, 2006

Trademark Owner History


Party NameBiosynth AG
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressStaad 9422
CH

Party NameBiosynth AG
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressStaad 9422
CH

Party NameBiosynth AG
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressStaad 9422
CH

Trademark Events


Event DateEvent Description
Tuesday, December 12, 2023NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
Tuesday, December 12, 2023REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Tuesday, December 12, 2023CASE ASSIGNED TO POST REGISTRATION PARALEGAL
Wednesday, June 14, 2023TEAS SECTION 8 & 15 RECEIVED
Monday, September 12, 2022COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Thursday, August 18, 2022TEAS CHANGE OF CORRESPONDENCE RECEIVED
Thursday, August 18, 2022ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Thursday, August 18, 2022TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Tuesday, September 12, 2017REGISTERED-PRINCIPAL REGISTER
Thursday, August 10, 2017NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Wednesday, August 9, 2017ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Wednesday, August 9, 2017STATEMENT OF USE PROCESSING COMPLETE
Tuesday, July 11, 2017USE AMENDMENT FILED
Saturday, August 5, 2017CASE ASSIGNED TO INTENT TO USE PARALEGAL
Tuesday, July 11, 2017TEAS STATEMENT OF USE RECEIVED
Tuesday, July 11, 2017TEAS CHANGE OF CORRESPONDENCE RECEIVED
Tuesday, January 17, 2017NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, November 22, 2016OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, November 22, 2016PUBLISHED FOR OPPOSITION
Wednesday, November 2, 2016NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, October 18, 2016LAW OFFICE PUBLICATION REVIEW COMPLETED
Monday, October 17, 2016ASSIGNED TO LIE
Friday, September 30, 2016APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, September 27, 2016EXAMINER'S AMENDMENT ENTERED
Tuesday, September 27, 2016NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
Tuesday, September 27, 2016EXAMINERS AMENDMENT E-MAILED
Tuesday, September 27, 2016EXAMINERS AMENDMENT -WRITTEN
Thursday, September 22, 2016ASSIGNED TO EXAMINER
Monday, June 20, 2016NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Thursday, June 16, 2016NEW APPLICATION ENTERED